Atlantic Fish, an emerging Raleigh company developing cultivated seafood, has received a $50,000 SEED grant from North ...

The post-award management of NCBiotech grants and loans is administered NCBiotech's Contracts and Grants Department. If you have questions related to budget changes, project extensions, reporting or ...

Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...

In this technical session, Creative Biolabs has invited Dr. Leyton to describe the need to develop a more precise method in investigating nuclear transport dynamics of NLS-therapeutics. Moreover, Dr.

RTI International has dedicated a new $67 million headquarters building on its Research Triangle Park campus as it marks its 60th year of business. The six-story Horizon building is the 23rd structure ...

The precision health ecosystem in North Carolina is strong and diverse. With deep expertise in big data and bioinformatics, North Carolina is leading the way for more personalized health and health ...

during a scientific and cultural exchange in Seoul, South Korea. Thaddeus Wadas, Ph.D., assistant professor of cancer biology at the Wake Forest University School of Medicine whose research has been ...

NCBiotech Library has expanded its life science-focused collection of market research reports. In addition to reports from BCC Research, the library now offers reports from Kalorama and Profound. Take ...

Attorney and business veteran Griffith “Griff” Kundahl has been named executive director of the Center of Innovation for Nanobiotechnology (COIN), a non-profit organization focused on expanding North ...

Did you know the average salary for a life sciences job in North Carolina is $112,000? That’s nearly twice the pay earned by other private-sector workers statewide. North Carolina employs 75,000 in ...

Istari Oncology, a young Research Triangle Park biotechnology company started by a world-famous Duke University brain cancer team, has reported rare positive results in a Phase 1 clinical trial of its ...